These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
412 related items for PubMed ID: 15498932
1. Tumor necrosis factor-related apoptosis-inducing ligand-mediated activation of mitochondria-associated nuclear factor-kappaB in prostatic carcinoma cell lines. Guseva NV, Taghiyev AF, Sturm MT, Rokhlin OW, Cohen MB. Mol Cancer Res; 2004 Oct; 2(10):574-84. PubMed ID: 15498932 [Abstract] [Full Text] [Related]
2. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling. Chen X, Kandasamy K, Srivastava RK. Cancer Res; 2003 Mar 01; 63(5):1059-66. PubMed ID: 12615723 [Abstract] [Full Text] [Related]
3. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells. Hermisson M, Weller M. Cell Death Differ; 2003 Sep 01; 10(9):1078-89. PubMed ID: 12934082 [Abstract] [Full Text] [Related]
4. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression. Huerta-Yepez S, Vega M, Jazirehi A, Garban H, Hongo F, Cheng G, Bonavida B. Oncogene; 2004 Jun 24; 23(29):4993-5003. PubMed ID: 15048072 [Abstract] [Full Text] [Related]
5. Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB. Ou D, Wang X, Metzger DL, Robbins M, Huang J, Jobin C, Chantler JK, James RF, Pozzilli P, Tingle AJ. Hum Immunol; 2005 Jul 24; 66(7):799-809. PubMed ID: 16112027 [Abstract] [Full Text] [Related]
6. Caspase-mediated p65 cleavage promotes TRAIL-induced apoptosis. Kim HS, Chang I, Kim JY, Choi KH, Lee MS. Cancer Res; 2005 Jul 15; 65(14):6111-9. PubMed ID: 16024612 [Abstract] [Full Text] [Related]
7. Regulation of intercellular adhesion molecule-1 gene by tumor necrosis factor-alpha is mediated by the nuclear factor-kappaB heterodimers p65/p65 and p65/c-Rel in the absence of p50. Aoudjit F, Brochu N, Bélanger B, Stratowa C, Hiscott J, Audette M. Cell Growth Differ; 1997 Mar 15; 8(3):335-42. PubMed ID: 9056676 [Abstract] [Full Text] [Related]
8. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB. Kasof GM, Lu JJ, Liu D, Speer B, Mongan KN, Gomes BC, Lorenzi MV. Oncogene; 2001 Nov 29; 20(55):7965-75. PubMed ID: 11753679 [Abstract] [Full Text] [Related]
9. Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas. Kumamoto H, Ooya K. J Oral Pathol Med; 2005 May 29; 34(5):287-94. PubMed ID: 15817072 [Abstract] [Full Text] [Related]
10. Adenovirus-mediated IKKbetaKA expression sensitizes prostate carcinoma cells to TRAIL-induced apoptosis. Sanlioglu AD, Koksal IT, Karacay B, Baykara M, Luleci G, Sanlioglu S. Cancer Gene Ther; 2006 Jan 01; 13(1):21-31. PubMed ID: 16052230 [Abstract] [Full Text] [Related]
11. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation. Tse AK, Wan CK, Shen XL, Yang M, Fong WF. Biochem Pharmacol; 2005 Nov 15; 70(10):1443-57. PubMed ID: 16181613 [Abstract] [Full Text] [Related]
12. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Zerbini LF, Wang Y, Cho JY, Libermann TA. Cancer Res; 2003 May 01; 63(9):2206-15. PubMed ID: 12727841 [Abstract] [Full Text] [Related]
13. Synovial fluid induced nuclear factor-kappaB DNA binding in a monocytic cell line. Lehmann T, Nguyen LQ, Handel ML. J Rheumatol; 2000 Dec 01; 27(12):2769-76. PubMed ID: 11128662 [Abstract] [Full Text] [Related]
14. Dual role of TMS1/ASC in death receptor signaling. Parsons MJ, Vertino PM. Oncogene; 2006 Nov 02; 25(52):6948-58. PubMed ID: 16715133 [Abstract] [Full Text] [Related]
15. Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Zhang L, Fang B. Cancer Gene Ther; 2005 Mar 02; 12(3):228-37. PubMed ID: 15550937 [Abstract] [Full Text] [Related]
16. Proteasome inhibition sensitizes hepatocellular carcinoma cells, but not human hepatocytes, to TRAIL. Ganten TM, Koschny R, Haas TL, Sykora J, Li-Weber M, Herzer K, Walczak H. Hepatology; 2005 Sep 02; 42(3):588-97. PubMed ID: 16037944 [Abstract] [Full Text] [Related]
17. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex. Izeradjene K, Douglas L, Delaney AB, Houghton JA. Cancer Res; 2004 Nov 01; 64(21):8036-44. PubMed ID: 15520213 [Abstract] [Full Text] [Related]
18. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation. Tse AK, Wan CK, Zhu GY, Shen XL, Cheung HY, Yang M, Fong WF. Mol Immunol; 2007 Apr 01; 44(10):2647-58. PubMed ID: 17240450 [Abstract] [Full Text] [Related]
19. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells. Morello S, Sorrentino R, Porta A, Forte G, Popolo A, Petrella A, Pinto A. J Cell Physiol; 2009 Nov 01; 221(2):378-86. PubMed ID: 19562684 [Abstract] [Full Text] [Related]
20. Potential mechanism of resistance to TRAIL-induced apoptosis in Burkitt's lymphoma. Tafuku S, Matsuda T, Kawakami H, Tomita M, Yagita H, Mori N. Eur J Haematol; 2006 Jan 01; 76(1):64-74. PubMed ID: 16343273 [Abstract] [Full Text] [Related] Page: [Next] [New Search]